These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 1021012

  • 1. Effect of a Rauscher leukemia virus vaccine upon chemical oncogenesis in the mouse.
    Basombrío MA, Pasqualini CD.
    Arch Geschwulstforsch; 1976; 46(8):630-3. PubMed ID: 1021012
    [Abstract] [Full Text] [Related]

  • 2. Murine sarcoma virus pseudotypes used as immunogens against viral and chemical oncogenesis.
    Basombrío MA, Mayer AM, Pasqualini CD.
    Cancer Res; 1977 Jun; 37(6):1768-76. PubMed ID: 192461
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. An approach to C-type virus immunoprevention of spontaneously occurring tumors in laboratory mice.
    Kelloff GJ, Peters RL, Donahoe RM, Ghazzouli I, Sass B, Nims RM, Huebner RJ.
    Cancer Res; 1976 Feb; 36(2 pt 2):622-30. PubMed ID: 175922
    [Abstract] [Full Text] [Related]

  • 5. Immunoprophylaxis of transplantable methylcholanthrene-induced murine fibrosarcomas by immunization with embryo cells expressing endogenous murine leukemia virus antigens.
    Zbar B, Manohar V, Sugimoto T, Ashley MP, Kato Y, Rappaport P.
    Cancer Res; 1981 Nov; 41(11 Pt 1):4499-507. PubMed ID: 6272979
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Protection of cats against progressive fibrosarcomas and persistent leukemia virus infection by vaccination with feline leukemia cells.
    Grant CK, de Noronha F, Tusch C, Michalek MT, McLane MF.
    J Natl Cancer Inst; 1980 Dec; 65(6):1285-92. PubMed ID: 6253714
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Antibodies to murine leukemia virus gp70 and p15(E) in sera of BALB/c mice immunized with syngeneic chemically induced sarcomas.
    Klitzman JM, Brown JP, Hellström KE, Hellström I.
    J Immunol; 1980 Jun; 124(6):2552-6. PubMed ID: 6246166
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cross-reactive cellular and humoral immunity to carcinogen-induced chicken fibrosarcomas. II. Effect of prior immunization with transplantable tumors on primary tumor incidence.
    Edelman AS, Xue B, Galton JE, Sanchez P, Thorbecke GJ.
    J Immunol; 1985 Sep; 135(3):2213-9. PubMed ID: 3926899
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.